IP Verse

Pharmaceutical Compositions Containing Dexketoprofen And Tramadol - EP2956129

The patent EP2956129 was granted to Laboratorios Menarini on Apr 18, 2018. The application was originally filed on Feb 6, 2014 under application number EP14705987A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2956129

LABORATORIOS MENARINI
Application Number
EP14705987A
Filing Date
Feb 6, 2014
Status
Opposition Rejected
Oct 30, 2020
Grant Date
Apr 18, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HOFFMANN EITLEJan 18, 2019- -
INTAS PHARMACEUTICALSJan 18, 2019ACCORD HEALTHCARE -

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONAU703310B
DESCRIPTIONEP0546676
DESCRIPTIONEP0759296
DESCRIPTIONUS5516803
DESCRIPTIONUS6294195
DESCRIPTIONWO2007008752
DESCRIPTIONWO2008092219
INTERNATIONAL-SEARCH-REPORTWO2008092219
INTERNATIONAL-SEARCH-REPORTWO2008150324
OPPOSITIONEP0759296
OPPOSITIONEP1739072
OPPOSITIONWO2007008752
OPPOSITIONWO2008092219
OPPOSITIONWO9411332

Non-Patent Literature (NPL) Citations (8) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- P. EKMEKGI et al., "The efficacy of adding dexketoprofen trometamol to tramadol with patient controlled analgesia technique in post-laparoscopic cholecystectomy pain treatment", Agri, (20120400), vol. 24, no. 2, pages 63 - 68, XP055551050
OPPOSITION- S. TUNCER et al., "Adding ketoprofen to intravenous patient-controlled analgesia with tramadol after major gynecological cancer surgery: A double-blinded, randomized, placebo-controlled clinical trial", Eur J Gynaecol Oncol., (20030000), vol. 24, no. 2, pages 181 - 4, XP008142044
OPPOSITION- TEVA, Label of tramadol hydrochloride 50 mg tablets, (20020619), URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/759771bl.pdf
OPPOSITION- THAKKAR et al., "A review on techniques for oral bioavailability enhancement of drugs", International Journal of Pharmaceutical Sciences Review and Research, (20101000), vol. 4, no. 3, pages 203 - 223, XP055551046
OPPOSITION- "tramadol 50 mg capsules", health products regulatory authority, (20181031), pages 1 - 109, XP055551058
OPPOSITION- H.F. MIRANDA et al., "Effects of tramadol and desketoprofen on analgesia and gastrointestinal transit in mice", Fundam Clin Pharmacol., (20090200), vol. 23, no. 1, pages 81 - 88, XP002699340
OPPOSITION- S.A. BOTHA et al., "COMPATIBILITY STUDY BETWEEN KETOPROFEN AND TABLET EXCIPIENTS USINGDIFFERENTIAL SCANNING CALORIMETRY", Drug Development and Industrial Pharmacy, (19890000), vol. 15, no. 3, pages 415 - 426, XP055551054
OPPOSITION- Kebm T. Savjani, et al, "Drug Solubility: Importance and Enhancement Techniques", International Scholarly Research Network, ISRN Pharmaceutics, (20120000), vol. 2012, pages 1 - 10, XP055551078

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents